ACB AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
The stock has been awarded the top rating for its value, but its dividend score is below 2. If the company starts distributing dividends, it may yield even better investment results.
ACB Current Performance
1.90%
Aurora cannabis inc
1.19%
Avg of Sector
1.11%
S&P500
Top 10 High Relevance to ACB
| Symbol | Company Name | Value | Trend | Swing Trading | Whale Interest | Dividend | Add to Watchlist |
|---|---|---|---|---|---|---|---|
CGC | Canopy growth corp | 2 | 3 | 2 | - | 1 | |
CRON | Cronos group inc | 4 | 3 | 2 | - | 1 | |
SNDL | Sndl inc | 4 | 5 | 2 | 1 | 1 | |
OGI | Organigram holdings inc | 2 | 3 | 2 | - | 1 | |
CRNX | Crinetics pharmaceuticals inc | 2 | 5 | 5 | 3 | 1 |
- CGC Canopy growth corpValue 2Trend 3Swing Trading 2Whale Interest -Dividend 1See more
ACB Profile
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company's segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Bradford Ontario, Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.